Search
Entera Bio Ltd
ENTXAdd to Watchlist
2.745USD
-0.055-1.96%
Close 09-25 16:00（ET）
472.83MMarket Cap
LossP/E TTM
Entera Bio Ltd (ENTX) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Entera Bio Ltd in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
10.000USD+257.14%
ENTX Analyst Recommendation Trends
In the current month, ENTX has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ENTX average Analyst price target in the last month is 10.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
ENTX Analyst Rating for Peer Comparison
Updated: Sep 25, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, ENTX EPS is projected to reach -0.080 in FY2026Q3, following reported EPS of -0.145 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.09
-0.07
-0.08
-0.08
-0.09
Actual
-0.06
-0.07
-0.14
--
--
Surprise
+29.11%
-4.84%
-81.16%
--
--
FAQs
What is Entera Bio Ltd's price target?
Analysts forecast that Entera Bio Ltd's price target is USD 9.00, with the highest forecast at USD 9.00 and the lowest forecast at USD 9.00.
How have Entera Bio LtdENTX's recent earnings per share performed?
The market expectation was USD -0.14, while Entera Bio LtdENTX's earnings per share (EPS) for the previous quarter was USD -0.07. EPS for the next quarter is expected at USD -0.08.
What is the analyst rating for Entera Bio Ltd?
Based on the ratings of Entera Bio Ltd's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.